Company intelligence / Profile preview

Chemisch-Pharmazeutische Fabrik Göppingen

Göppingen, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Chemisch-Pharmazeutische Fabrik Göppingen is a German specialty pharmaceutical company best known for developing and marketing ERr 731, a proprietary standardized extract of Rheum rhaponticum (rhubarb root), which is used for the treatment of menopausal symptoms; postmarketing data show the product is generally safe with a low incidence of adverse events[4][5].

Therapeutic areas: Women's Health
Modalities: Small moleculeHerbal extract
Industry: Biotech

Drug pipeline

1 asset

ERr 731

Unknown

Partnerships

Dr. Loges + Co. GmbH (Germany, marketing/authorization partner for femi-loges)[4][5]Metagenics (US distributor for Estrovera)[5]

Beyond the preview

Go deeper on Chemisch-Pharmazeutische Fabrik Göppingen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemisch-Pharmazeutische Fabrik Göppingen.